Other
Function
1
Pipeline Programs↗
55
Active Trials↗
64
Companies Involved↗
Function is an early-stage landscape with 1 program across 64 companies. The most active players are Eli Lilly, Pfizer, GSK.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 21
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
511
clinical trials
Completed334 · 65%
Unknown status69 · 14%
Recruiting37 · 7%
Terminated34 · 7%
Withdrawn18 · 4%
Not yet recruiting12 · 2%
Other7 · 1%
Clinical Trials
Trial Activity
511 trials
Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)
Recruiting·—·Phase 2·NCT05275686·80 enrolled
The Effect of Naldemedine on Opioid-induced Bowel Dysfunction
Recruiting·—·Phase 2·NCT06334198·20 enrolled
Page 1 of 35
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)